The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Market Value Of The Chemotherapy Market Projected To Expand During 2026–2030?
The chemotherapy market has experienced significant expansion in recent years. It will grow from $37.27 billion in 2025 to $41.95 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. Historically, this expansion can be attributed to factors such as the increasing prevalence of cancer, rising government healthcare expenditure, advancements in chemotherapeutic drugs, the growth of hospital infrastructure, and the adoption of intravenous chemotherapy.
The chemotherapy market is anticipated to undergo significant expansion in the near future. Its valuation is projected to reach $68.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period is primarily driven by the broader adoption of precision medicine, the development of targeted therapies, increased awareness regarding home-based chemotherapy options, the integration of digital health solutions, and a rising demand for combination treatments. Noteworthy trends for the upcoming period include personalized chemotherapy regimens, the embrace of oral chemotherapy, the advancement of combination drug therapies, the delivery of chemotherapy in home settings, and innovations in advanced infusion device technologies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp
Which Growth Drivers Are Expected To Support The Chemotherapy Market Forward?
The rising incidence of cancer is anticipated to drive the expansion of the chemotherapy market in the future. Cancer is characterized by the uncontrolled proliferation of certain body cells which then spread to other regions. Chemotherapy involves the use of potent chemicals, either singly or combined, to treat cancer by eradicating rapidly multiplying cancer cells. Consequently, the growing occurrence of cancer will boost the need for chemotherapy. For example, the World Health Organization, a United Nations specialized agency based in Switzerland, reported in February 2024 that more than 35 million new cancer cases are projected for 2025, representing a 77% surge from the estimated 20 million cases in 2022. Thus, the escalating cancer prevalence is a key factor propelling the chemotherapy market.
How Is Segment Classification Applied In The Chemotherapy Market?
The chemotherapy market covered in this report is segmented –
1) By Product Type: Pump, Cannula, Catheter, Other Product Types
2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer
3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs
4) By Route Of Administration: Oral, Intravenous
5) By End User: Hospitals, Research Institutes, Other End Users
Subsegments:
1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps
2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports
3) By Catheter: Chemotherapy Catheters, PICC Lines
4) By Other Product Types: Safety Devices, IV Sets, Administration Sets
What Trends Are Influencing The Chemotherapy Market?
Leading companies in the chemotherapy market are prioritizing the formation of strategic partnerships to facilitate the commercial launch of innovative medical devices that assist in chemotherapy services. These alliances aim to harness the individual strengths and resources of each partner to accelerate breakthroughs in cancer treatment, improve patient outcomes, and address existing unmet medical needs. For instance, in March 2023, EVERSANA, a US-based global services provider for the life sciences industry, entered into a partnership with ChemoMouthpiece LLC, a US-based medical device company. This collaboration was established to support the launch and commercialization of its medical device, the Chemo Mouthpiece, intended to help oncology patients across the United States. The Chemo Mouthpiece functions as an intraoral ice pack, delivering cryotherapy to the oral cavity of a patient undergoing chemotherapy, effectively preventing and treating oral mucositis, a common and extremely painful chemotherapy side effect.
Which Organizations Are Involved In The Chemotherapy Market?
Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.
Access The Complete Chemotherapy Market Report:
https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report
Which Region Leads The Chemotherapy Market By Size?
North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Chemotherapy Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp
Browse Through More Reports Similar to the Global Chemotherapy Market 2026, By The Business Research Company
Chemotherapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report
Chemotherapy At Home Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report
Oncology Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model